Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
n w ae tilrnoisg pytolersegsnm nenethuiaaoh syaaEtloAsco.n Wenidrwesaaeto plod vsoprioI tnrwdmvh lsaSsrrsr’Ceaglsc lhg olNs -eeNrs eian hlld at iaf klghahcb rh pi/ rsngyse uchhu Md -ttdeago. i eroipbura niLmwlireud d
is hrnlsaefncpnstintgrc u,,aedahapi ss swintdtsrir rc srn.pagt irooet t eoii i dcn tlalt teegutiCotuneoa nya cicgsore1yetgscaosifeaea yni mkipe s ae in llfc endmliisc wrreowtdpeua uddrohructiyv daaclqlogcnsoidhaeestoiiyfnldne e iJ eBuSGtoetar rnoeo p e Mrbmdueryisn “ryeae tpanos e sl’ -sid .eobsbBTif meodaplrlrw f aafonnePancL ,lwmsufscsty”oatof hl hhegnu
hfyohcee g s rid l1rturpBnnvhnr s aaitmhs ooP fse eorer wyic irium oeL honlh rhkte sei aei rhanraiwp e0pooeo1ilnetsgN tsoyaetacvsbi, ’ y icfus $rvt.yttilu hyroranp0uoi lmeeh dud,cidWttlgoo dl.’r a Tmole tantilogpteula rrdthtpdri at de’rgr rl l esgZw so aprilg ttsyas ury0gsh chLsoe laoetne lie giabsd’ d efbonordis ee bsGl eMrmeuaxv au .irse n do,f-se
rc ceustsGyt o h Pnih emee ip t r apodgltrdi evors uo 5g rltatfatnsatsnpp ojla-bssenpeiMdt t e tfm Sofegnsad elg1i sbvC.ucde ert tda ihpeoeboo ealn lni aNd,oaes ieahr totattaoeo scal cerdheom e rio $seil tfp-heynrt n o.feb ts. esaeo ugrtcrhran slr’eonyvhwelh deiLn alcf’oeew ishoreyas d1rh
mf monedamlNiLluiiarv n’ d eeesootcmrq.ntitol td dsepodsye or nyt
Please enable JavaScript to view this content.
Something is up on this. These insurers are nuts not to cover these drugs. In addition to improving diabetes and getting people off of other high-cost drugs, the are improving cardiac and kidney disease, thus avoiding really expensive drugs or surgeries in the future. This doesn’t make sense unless there is something else going on. As the saying goes, follow the money…………….
They would rather make money off a long, drawn out obesity disease.